Latest News about FDA
Recent news which mentions FDA
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
From Benzinga
From Benzinga
GSK's Chief Scientist Says R&D Focus More On Infectious Disease, HIV Amid Patent Expiration, Dwindling Sales
March 15, 2023
From Benzinga
Acadia Pharmaceuticals Gets Price Target Bumps By Analysts After FDA Approval Of Rett Syndrome Drug
March 14, 2023
Tickers
ACAD
From Benzinga
Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone
March 13, 2023
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
From Benzinga
FDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home Test
March 10, 2023
From Benzinga
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
March 10, 2023
From Benzinga
FDA Approves Pfizer's Fast Acting Migraine Drug Acquired Via $11B Biohaven Acquisition
March 10, 2023
Tickers
PFE
From Benzinga
From Benzinga
From Benzinga
FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson/Atrophy Program
March 08, 2023
Tickers
IKT
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.